Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |